BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10562311)

  • 1. At the crossroads of inflammation and tumorigenesis.
    Cordon-Cardo C; Prives C
    J Exp Med; 1999 Nov; 190(10):1367-70. PubMed ID: 10562311
    [No Abstract]   [Full Text] [Related]  

  • 2. A proinflammatory cytokine inhibits p53 tumor suppressor activity.
    Hudson JD; Shoaibi MA; Maestro R; Carnero A; Hannon GJ; Beach DH
    J Exp Med; 1999 Nov; 190(10):1375-82. PubMed ID: 10562313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53--the link between inflammation and cancer?
    Portwine C
    Pediatr Res; 2000 May; 47(5):573. PubMed ID: 10813577
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophage migration inhibitory factor: a probable link between inflammation and cancer.
    Bucala R; Donnelly SC
    Immunity; 2007 Mar; 26(3):281-5. PubMed ID: 17376392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis.
    Leech M; Lacey D; Xue JR; Santos L; Hutchinson P; Wolvetang E; David JR; Bucala R; Morand EF
    Arthritis Rheum; 2003 Jul; 48(7):1881-9. PubMed ID: 12847682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation: what role in pediatric cancer?
    Morgenstern DA; Anderson J
    Pediatr Blood Cancer; 2012 May; 58(5):659-64. PubMed ID: 22162439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.
    Mitchell RA; Liao H; Chesney J; Fingerle-Rowson G; Baugh J; David J; Bucala R
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):345-50. PubMed ID: 11756671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient deletion of apoptotic cells by macrophage migration inhibitory factor (MIF) overexpression accelerates photocarcinogenesis.
    Honda A; Abe R; Yoshihisa Y; Makino T; Matsunaga K; Nishihira J; Shimizu H; Shimizu T
    Carcinogenesis; 2009 Sep; 30(9):1597-605. PubMed ID: 19584138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting.
    Fingerle-Rowson G; Petrenko O; Metz CN; Forsthuber TG; Mitchell R; Huss R; Moll U; Müller W; Bucala R
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9354-9. PubMed ID: 12878730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of a continuous macrophage-like cell line to MIF.
    Newman W; Diamond B; Flomenberg P; Scharff MD; Bloom BR
    J Immunol; 1979 Nov; 123(5):2292-7. PubMed ID: 385779
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF).
    Mitchell RA; Bucala R
    Semin Cancer Biol; 2000 Oct; 10(5):359-66. PubMed ID: 11100884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of inflammation- and angiogenesis-related gene expression in breast cancer cells and co-cultured macrophages.
    Burnett GT; Weathersby DC; Taylor TE; Bremner TA
    Anticancer Res; 2008; 28(4B):2093-9. PubMed ID: 18751381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway.
    Petrenko O; Moll UM
    Mol Cell; 2005 Jan; 17(2):225-36. PubMed ID: 15664192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 in life and death.
    Shimamura A; Fisher DE
    Clin Cancer Res; 1996 Mar; 2(3):435-40. PubMed ID: 9816188
    [No Abstract]   [Full Text] [Related]  

  • 15. NFκB/p53 crosstalk-a promising new therapeutic target.
    Schneider G; Krämer OH
    Biochim Biophys Acta; 2011 Jan; 1815(1):90-103. PubMed ID: 20951769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UICC study group on basic and clinical cancer research: interrelations of signaling paths and what we can learn from interfering with them.
    Burger MM
    J Cell Biochem; 2002; 84(3):433-8. PubMed ID: 11813248
    [No Abstract]   [Full Text] [Related]  

  • 17. Impaired DNA damage checkpoint response in MIF-deficient mice.
    Nemajerova A; Mena P; Fingerle-Rowson G; Moll UM; Petrenko O
    EMBO J; 2007 Feb; 26(4):987-97. PubMed ID: 17290223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 is a suppressor of inflammatory response in mice.
    Komarova EA; Krivokrysenko V; Wang K; Neznanov N; Chernov MV; Komarov PG; Brennan ML; Golovkina TV; Rokhlin OW; Kuprash DV; Nedospasov SA; Hazen SL; Feinstein E; Gudkov AV
    FASEB J; 2005 Jun; 19(8):1030-2. PubMed ID: 15811878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammation is regarded as a strong promoter of tumorigenesis.
    Kyewski B; Romero P
    Int J Cancer; 2010 Aug; 127(4):747. PubMed ID: 20564540
    [No Abstract]   [Full Text] [Related]  

  • 20. p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure.
    Shimizu I; Yoshida Y; Katsuno T; Tateno K; Okada S; Moriya J; Yokoyama M; Nojima A; Ito T; Zechner R; Komuro I; Kobayashi Y; Minamino T
    Cell Metab; 2012 Jan; 15(1):51-64. PubMed ID: 22225876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.